Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704945 | SCV000238036 | likely benign | not provided | 2019-03-04 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000538379 | SCV000643701 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390484 | SCV002670594 | benign | Cardiovascular phenotype | 2020-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001704945 | SCV003825869 | uncertain significance | not provided | 2022-06-09 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001704945 | SCV001978489 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001704945 | SCV001980588 | uncertain significance | not provided | no assertion criteria provided | clinical testing |